Recombinant CSF1R (Cabiralizumab Biosimilar) antibody

Catalog No. ABIN7597573

The Humanized Chimeric anti-CSF1R (Cabiralizumab Biosimilar) antibody has been validated for . It is suitable to detect CSF1R (Cabiralizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant CSF1R (Cabiralizumab Biosimilar) antibody (ABIN7597573)

Target: CSF1R (Cabiralizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CSF1R (Cabiralizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CSF1R (Cabiralizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Cabiralizumab Biosimilar Antibody

Specificity: CD115, CSF-1 receptor, CSF1R, M-CSF-R, CSF-1-R, Proto-oncogene c-Fms, Macrophage colony-stimulating factor 1 receptor, CSF-1R, FMS

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CSF1R (Cabiralizumab Biosimilar)

Target: CSF1R (Cabiralizumab Biosimilar)

Alternative Name: Cabiralizumab Biosimilar

Target Type: Biosimilar

Background: CD115, CSF-1 receptor, CSF1R, M-CSF-R, CSF-1-R, Proto-oncogene c-Fms, Macrophage colony-stimulating factor 1 receptor, CSF-1R, FMS

UniProt: P07333

CAS-No: 1613144-80-1